Research Topics
Genomes and GenesSpecies | J ZarranzSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementiaJuan J Zarranz
Department of Neurology, de Cruces Hospital, Departament of Neuroscience, University del Pais Vasco, Baracaldo, Vizcaya, Spain
Ann Neurol 55:164-73. 2004..Our data show that, in addition to the previously described hereditary alpha-synucleinopathies, dementia with Lewy bodies is related to mutation of alpha-synuclein...
Phenotypic variability in familial prion diseases due to the D178N mutationJ J Zarranz
Neurology Service, Hospital Cruces, Department of Neurosciences, University of the Basque Country, 48903 Baracaldo, Vizcaya, Spain
J Neurol Neurosurg Psychiatry 76:1491-6. 2005....
Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndromeJuan J Zarranz
Neurology Service, Hospital de Cruces, Department of Neurosciences, University of the Basque Country, Baracaldo, Vizcaya, Spain
Mov Disord 21:107-11. 2006....
Abnormal sleep architecture is an early feature in the E46K familial synucleinopathyJuan J Zarranz
Neurology Service, Hospital of Cruces, Department of Neurosciences, University of the Basque Country, Baracaldo, Vizcaya, Spain
Mov Disord 20:1310-5. 2005..REM sleep behavior disorder could not be recorded in any case. Our findings expand the spectrum of sleep disorders reported in synucleinopathies whether sporadic or familial...
A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron diseaseJ J Zarranz
Neurology Service, Department of Neurosciences, Hospital Cruces, University of the Basque Country, Baracaldo, Vizcaya, Spain
Neurology 64:1578-85. 2005..In some families the genetic basis is still unknown. The authors report two pedigrees with FTDP-17 harboring a novel mutation (K317M) in exon 11 in the MAPT gene...
[From empiricism to neuroscience in Alzheimer's disease]J Zarranz
Departamento de Neurologia, Hospital de Cruces, Barakaldo, Vizcaya, Spain
Rev Neurol 39:576-82. 2004....
Familial prion diseases in the Basque Country (Spain)Juan J Zarranz
Service of Neurology, Hospital Cruces, Department of Neurosciences, University of the Basque Country, Baracaldo, Spain
Neuroepidemiology 24:103-9. 2005..Further genetic and genealogical studies should resolve this issue...
[Prevalence of dementia in the elderly aged above 65 in a district in the Basque Country]M Fernandez
Hospital de Cruces, 48903 Baracaldo, Espana
Rev Neurol 46:89-96. 2008..To estimate the prevalence of dementia in the population aged above 65 in the district of Mungialde, Vizcaya...
Ancestral origins of the prion protein gene D178N mutation in the Basque CountryAna B Rodríguez-Martínez
Unidad de Genómica Banco de ADN y Genotipado, Facultad de Farmacia, Universidad del Pais Vasco, Vitoria Gasteiz, Spain
Hum Genet 117:61-9. 2005..We propose that "happy typing" constitutes an efficient method for determining disease-associated haplotypes, since the analysis of a single affected individual per pedigree should provide sufficient evidence...
Lrrk2-associated parkinsonism is a major cause of disease in Northern SpainMaría C González-Fernández
Servicio General de Investigación Genómica, Banco de ADN and Departamento de Z y Biología Celular A, Universidad del Pais Vasco, Vitoria Gasteiz, Spain
Parkinsonism Relat Disord 13:509-15. 2007..Our findings highlight the importance of Lrrk2 parkinsonism in this population and may have important consequences for its extended Diaspora in North, Central and South Americas...
Use of ziprasidone in parkinsonian patients with psychosisJuan Carlos Gómez-Esteban
Neurology Service, Hospital of Cruces, Baracaldo, Vizcaya, Spain
Clin Neuropharmacol 28:111-4. 2005..Although controlled trials are needed, the findings suggest that ziprasidone may be effective in parkinsonian patients with psychosis...
Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case reportElena Lezcano
Service of Neurology, Hospital of Cruces, Neurosciences Department, University of the Basque Country, Spain
Mov Disord 19:973-7. 2004..Because the subject complied with all the inclusion criteria (Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease), bilateral subthalamic nucleus deep brain stimulation electrodes were implanted...
Restless legs syndrome in Parkinson's diseaseJuan C Gómez-Esteban
Neurology Service, Movement Disorders Unit, Hospital Cruces, Baracaldo, Vizcaya
Mov Disord 22:1912-6. 2007..It would be advisable to validate the diagnostic criteria of RLS in this specific group of patients...
Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin geneJuan C Gómez-Esteban
Movement Disorders Unit, Neurology Service, Cruces Hospital, Baracaldo, Vizcaya, Spain
Neurosurgery 62:857-62; discussion 862-3. 2008..The present study analyzes the postoperative outcome of deep brain subthalamic stimulation in patients carrying the R1441G mutation in the leucine-rich repeat kinase-2 (LRRK2) (dardarin) gene...
